In an era of health reform, diagnostic technologies that focus on prevention and test the viability of expensive treatment options are becoming increasingly valuable to health providers, payers, and patients. Historically, investment in this sector has not seen the vigor demonstrated with medical devices or biotech innovations. However, in today’s environment, diagnostics are becoming attractive opportunities for companies looking for collaborations or acquisitions as well as investors looking for cutting-edge technologies, all creating a robust industry on the brink of breaking through to the mainstream.
In this presentation, panelists will:
- Provide insight on the diagnostic industry on a local and national level
- Discuss key elements that are reviewed when assessing start-up opportunities
- Discuss where opportunities exist for maximizing profits
- Provide new strategies for raising funds in this dynamic marketplace
Panelists:
Stephen DiPalma, Chief Financial Officer, Envivo Pharmaceuticals
Ronald S. Eppen, Partner, Foley & Lardner LLP
Mitchell Sanders, CEO and Founder, ECI Biotech
Related Insights
23 April 2025
Events
Rooftop Reception at IAPP Global Privacy Summit 2025
Following the first day of the International Association of Privacy Professionals’ 2025 Global Privacy Summit, Foley & Lardner’s Cybersecurity & Data Privacy team will be hosting a networking reception on the rooftop of The Delegate, conveniently located across the street from the venue.
13 March 2025
Foley Ignite
New Opportunities and Challenges for Board Directors
Foley & Lardner LLP recently co-hosted a webinar with the National Association of Corporate Directors to discuss how a new presidential administration and evolving state-driven regulations are effecting boardrooms.
27 March 2025
Events
Administrative Enforcement: Collateral Consequences of Compliance Failures
Foley partner Judy Waltz, chair of Foley’s Health Care Practice Group, is speaking in the American Health Law Association Institute (AHLA) on Medicare and Medicaid Payment Issues in the session “Administrative Enforcement: Collateral Consequences of Compliance Failures” on March 27.